MG O-12:5 (BioDeep_00000631479)

   


代谢物信息卡片


1-O-(1E,3E,5E,7E,9E-dodecapentenyl)-sn-glycerol

化学式: C15H22O3 (250.1568862)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: [C@](CO)([H])(O)CO/C=C/C=C/C=C/C=C/C=C/CC
InChI: InChI=1S/C15H22O3/c1-2-3-4-5-6-7-8-9-10-11-12-18-14-15(17)13-16/h3-12,15-17H,2,13-14H2,1H3/b4-3+,6-5+,8-7+,10-9+,12-11+/t15-/m0/s1

描述信息

同义名列表

3 个代谢物同义名

1-O-(1E,3E,5E,7E,9E-dodecapentenyl)-sn-glycerol; Fecapentaene-12; MG O-12:5



数据库引用编号

2 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • M M Nordling, B Glinghammar, P C Karlsson, T M C M de Kok, J J Rafter. Effects on cell proliferation, activator protein-1 and genotoxicity by fecal water from patients with colorectal adenomas. Scandinavian journal of gastroenterology. 2003 May; 38(5):549-55. doi: NULL. [PMID: 12795469]
  • T M de Kok, J M van Maanen. Evaluation of fecal mutagenicity and colorectal cancer risk. Mutation research. 2000 Jul; 463(1):53-101. doi: 10.1016/s1383-5742(00)00003-x. [PMID: 10838209]
  • T M de Kok, D M Pachen, J M van Maanen, M V Lafleur, E J Westmijze, F ten Hoor, J C Kleinjans. Role of oxidative DNA damage in the mechanism of fecapentaene-12 genotoxicity. Carcinogenesis. 1994 Nov; 15(11):2559-65. doi: 10.1093/carcin/15.11.2559. [PMID: 7955106]
  • T M de Kok, M L van Iersel, F ten Hoor, J C Kleinjans. In vitro study on the effects of fecal composition on fecapentaene kinetics in the large bowel. Mutation research. 1993 Jun; 302(2):103-8. doi: 10.1016/0165-7992(93)90011-j. [PMID: 7684504]
  • A C Povey, V L Wilson, J L Zweier, P Kuppusamy, I K O'Neill, C C Harris. Detection by 32P-postlabelling of DNA adducts induced by free radicals and unsaturated aldehydes formed during the aerobic decomposition of fecapentaene-12. Carcinogenesis. 1992 Mar; 13(3):395-401. doi: 10.1093/carcin/13.3.395. [PMID: 1547529]
  • R A Jacob, D S Kelley, F S Pianalto, M E Swendseid, S M Henning, J Z Zhang, B N Ames, C G Fraga, J H Peters. Immunocompetence and oxidant defense during ascorbate depletion of healthy men. The American journal of clinical nutrition. 1991 12; 54(6 Suppl):1302S-1309S. doi: 10.1093/ajcn/54.6.1302s. [PMID: 1962587]
  • P P Nair, S Shami, E Sainz, J T Judd, P R Taylor, A Schatzkin. Quantitative assessment of the genotoxicity of fecapentaenes. Mutation research. 1991 Jun; 260(2):153-7. doi: 10.1016/0165-1218(91)90003-5. [PMID: 1904547]
  • T M de Kok, F ten Hoor, J C Kleinjans. Identification and quantitative distribution of eight analogues of naturally occurring fecapentaenes in human feces by high-performance liquid chromatography. Carcinogenesis. 1991 Feb; 12(2):199-205. doi: 10.1093/carcin/12.2.199. [PMID: 1995185]
  • D G Kingston, R L Van Tassell, T D Wilkins. The fecapentaenes, potent mutagens from human feces. Chemical research in toxicology. 1990 Sep; 3(5):391-400. doi: 10.1021/tx00017a001. [PMID: 2133089]
  • J B Block, M F Dietrich, R Leake, S A Laidlaw, N E Vinton, J D Kopple. Fecapentaene excretion: aspects of excretion in newborn infants, children, and adult normal subjects and in adults maintained on total parenteral nutrition. The American journal of clinical nutrition. 1990 Apr; 51(4):698-704. doi: 10.1093/ajcn/51.4.698. [PMID: 2108580]
  • J H Weisburger, R C Jones, C X Wang, J Y Backlund, G M Williams, D G Kingston, R L Van Tassell, R F Keyes, T D Wilkins, P P de Wit. Carcinogenicity tests of fecapentaene-12 in mice and rats. Cancer letters. 1990 Feb; 49(2):89-98. doi: 10.1016/0304-3835(90)90143-l. [PMID: 2306713]
  • G A Kivits, B C de Boer, D H Nugteren, M van der Steeg, L B Vertegaal, A van der Gen. Quantitative HPLC analysis of the level of fecapentaenes and their precursors in human feces by a chemical conversion method. Journal of natural products. 1990 Jan; 53(1):42-9. doi: 10.1021/np50067a004. [PMID: 2348203]
  • J M Dypbukt, C C Edman, K Sundqvist, T Kakefuda, S M Plummer, C C Harris, R C Grafström. Reactivity of fecapentaene-12 toward thiols, DNA, and these constituents in human fibroblasts. Cancer research. 1989 Nov; 49(21):6058-63. doi: NULL. [PMID: 2790820]
  • M H Schiffman, R L Van Tassell, A Robinson, L Smith, J Daniel, R N Hoover, R Weil, J Rosenthal, P P Nair, S Schwartz. Case-control study of colorectal cancer and fecapentaene excretion. Cancer research. 1989 Mar; 49(5):1322-6. doi: NULL. [PMID: 2917361]
  • M Shioya, K Wakabayashi, K Yamashita, M Nagao, T Sugimura. Formation of 8-hydroxydeoxyguanosine in DNA treated with fecapentaene-12 and -14. Mutation research. 1989 Mar; 225(3):91-4. doi: 10.1016/0165-7992(89)90123-1. [PMID: 2927433]
  • J C Kleinjans, M H Pluijmen, G J Hageman, H Verhagen. Stabilization and quantitative analysis of fecapentaenes in human feces, using synthetic fecapentaene-12. Cancer letters. 1989 Jan; 44(1):33-7. doi: 10.1016/0304-3835(89)90104-3. [PMID: 2917340]
  • M Bauchinger, R Bartha, E Schmid, H R Pfaendler. Fecapentaene causes sister-chromatid exchanges in human lymphocytes. Mutation research. 1988 Sep; 209(1-2):29-31. doi: 10.1016/0165-7992(88)90106-6. [PMID: 3173400]
  • W R Bruce. Steps between diet and colon cancer. Progress in clinical and biological research. 1988; 279(?):123-30. doi: NULL. [PMID: 3054914]
  • S V Govindan, D G Kingston, A A Gunatilaka, R L van Tassell, T D Wilkins, P P de Wit, M van der Steeg, A van der Gen. Synthesis and biological activity of analogs of fecapentaene-12. Journal of natural products. 1987 Jan; 50(1):75-83. doi: 10.1021/np50049a011. [PMID: 3598600]
  • S M Plummer, R C Grafstrom, L L Yang, R D Curren, K Linnainmaa, C C Harris. Fecapentaene-12 causes DNA damage and mutations in human cells. Carcinogenesis. 1986 Sep; 7(9):1607-9. doi: 10.1093/carcin/7.9.1607. [PMID: 3742732]
  • R L Van Tassell, T D Wilkins. The precursors of fecapentaenes. A preliminary report. Annali dell'Istituto superiore di sanita. 1986; 22(3):933-41. doi: NULL. [PMID: 3826998]
  • J J Krepinsky, W R Bruce, I Gupta, K Suzuki, J J Rafter, P Child. Diet-related factors in the origin of cancer of the large bowel--a molecular scientist's point of view. Progress in clinical and biological research. 1986; 206(?):183-97. doi: NULL. [PMID: 3952089]
  • R L Van Tassell, R M Schram, T D Wilkins. Microbial biosynthesis of fecapentaenes. Progress in clinical and biological research. 1986; 206(?):199-211. doi: NULL. [PMID: 3952090]
  • N Hirai, D G Kingston, R L Van Tassell, T D Wilkins. Isolation and structure elucidation of fecapentaenes-12, potent mutagens from human feces. Journal of natural products. 1985 Jul; 48(4):622-30. doi: 10.1021/np50040a017. [PMID: 4045474]
  • J Baptista, W R Bruce, I Gupta, J J Krepinsky, R L van Tassell, T D Wilkins. On distribution of different fecapentaenes, the fecal mutagens, in the human population. Cancer letters. 1984 Apr; 22(3):299-303. doi: 10.1016/0304-3835(84)90166-6. [PMID: 6713371]
  • I Gupta, J Baptista, W R Bruce, C T Che, R Furrer, J S Gingerich, A A Grey, L Marai, P Yates, J J Krepinsky. Structures of fecapentaenes, the mutagens of bacterial origin isolated from human feces. Biochemistry. 1983 Jan; 22(2):241-5. doi: 10.1021/bi00271a001. [PMID: 6824628]